TSPO EXPRESSION IN PATIENTS WITH DIFFERENT CLINICAL AND MORPHOLOGICAL TYPES OF RENAL CELL CARCINOMA


如何引用文章

全文:

详细

The paper presents the results of an investigation of the expression of peripheral benzodiazepine receptor (TsPO) in patients with renal cell carcinoma in relation to gender, age, disease stage, histological type, and comorbid diseases. In the patients with renal cell carcinoma, the level of TsPO was found to be related to the disease stage, histological type, and the presence of synchronous cancer at other sites. The findings may suggest that TsPO can be used as a marker in predicting the efficiency of treatment and the course of disease.

作者简介

R. Zukov

Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical University

Email: zukov_rus@mail.ru
канд. мед. наук, доц. каф. онкологии и лучевой терапии 660022, Красноярск, ул. Партизана Железняка, 1

O. Polyakova

Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical University

T. Ruksha

Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical University

Yu. Dykhno

Prof. V. F. Voino-Yasenetsky Krasnoyarsk State Medical University

T. Maksimova

A. I. Kryzhanovsky Krasnoyarsk Territorial Clinical Oncology Dispensary

参考

  1. Cheville J. S., Lohse C. M., Zincke H. et al. // Am. J. Surg. Pathol. 2003. Vol. 27, N 5. P. 612-624.
  2. Delahunt B., Eble J. N., McCredie M. R. et al. // Hum. Pathol. 2001. Vol. 32, N 6. P 590-595.
  3. Everett H., Barry M., Sun X. et al. // J. Exp. Med. 2002. Vol. 196, N 9. P. 1127-1140.
  4. Galiegue S., Casellas P., Kramar A. et al. // Clin. Cancer Res. 2004. Vol. 10. P. 2058-2064.
  5. Gavish M., Laor N., Bidder M. et al. // Neuropsychopharmacology. 1996. Vol. 14, N 3. P. 181-186.
  6. Han Z., Slack R. S., Li W. et al. // J. Recept. Signal Transduct. Res. 2003. Vol. 23, N 2-3. P. 225-238.
  7. Johnson M. R., Marazziti D., Brawman-Mintzer O. et al. // Biol. Psychiatry. 1998. Vol. 43, N 4. P. 306-309.
  8. Kurumaji A., Nomoto H., Yamada K. et al. // Am. J. Med. Genet. 2001. Vol. 105, N 2. P. 172-175.
  9. Lin D., Chang Y. J., Strauss J. F. et al. // Genomics. 1993. - Vol. 18, N 3. P. 643-650.
  10. Linehan W. M., Zbar B. // Cancer Cell. 2004. Vol. 6. - P. 223-228.
  11. Maaser K., Grabowski P., Sutter A. P. et al. // Clin. Cancer Res. 2002. Vol. 8. P. 3205-3209.
  12. Molina A. M., Tickoo S. K., Ishill N. et al. // J. Clin. Oncol. 2009. Vol. 27, N 15S. P. 16017.
  13. Papadopoulos V., Baraldi M., Guilarte T. R. et al. // Trends Pharmacol. Sci. 2006. Vol. 27, N 8. P. 402-409.
  14. Patard J.-J., Kim H. L., Lam J. S. et al. // J. Clin. Oncol. 2004. Vol. 22, N 16. P. 3316-3322.
  15. Patard J.-J., Leray E., Rioux-Leclercq N. et al. // J. Clin. Oncol. 2005. Vol. 23, N 12. P. 2763-2771.
  16. Pignot G., Elie C., Conquy S. et al. // J. Urology. 2007. Vol. 69, N 2. P. 230-235.
  17. Ruff M. R., Pert C. B., Weber R. J. et al. // Science. 1985. - Vol. 229. P. 1281-1283.
  18. Taliani S., Simorini F., Sergianni V. et al. // J. Med. Chem. 2007. Vol. 50, N 2. P. 404-407.
  19. Veenman L., Gavish M. // Pharmacol. Ther. 2006. Vol. 110, N 3. P. 503-524.

版权所有 © Eco-Vector, 2012


 


##common.cookie##